David J. Barker

Dr. David J. Barker


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2021 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
CBCarissa A. Bruno
Carissa A. Bruno
COChris O'Brien
Chris O'Brien
SBSvetlana Bryant
Svetlana Bryant
JMJennifer I. Mejaes
Jennifer I. Mejaes
DEDavid J. Estrin
David J. Estrin
DBDavid J. Barker
David J. Barker

13 May 2024 in Nature Neuroscience
Verified
Journal Article
Open access
PDF file
SMSamuel J. Millard
Samuel J. Millard
IHIvy B. Hoang
Ivy B. Hoang
SSSavannah Sherwood
Savannah Sherwood
MTMasakazu Taira
Masakazu Taira
VRVanessa Reyes
Vanessa Reyes
MSMelissa J. Sharpe
Melissa J. Sharpe
Dopamine neurons in the ventral tegmental area support intracranial self-stimulation (ICSS), yet the cognitive representations underlying this phenomenon remain unclear. Here, 20-Hz stimulation of dopamine neurons, which approximates a physiologically relevant prediction error, was not sufficient to support ICSS beyond a continuously reinforced schedule and did not endow cues with a general or specific value. However, 50-Hz stimulation of dopamine neurons was sufficient to drive robust ICSS and was represented as a specific reward to motivate behavior. The frequency dependence of this effect is due to the rate (not the number) of action potentials produced by dopamine neurons, which differently modulates dopamine release downstream.

1 December 2016 in Addiction Biology
Verified
Journal Article
Open access
PDF file
SSSteven J. Simmons
Steven J. Simmons
RGRyan A. Gregg
Ryan A. Gregg
FTFionya H. Tran
Fionya H. Tran
LMLili Mo
Lili Mo
EWEva von Weltin
Eva von Weltin
JMJohn W. Muschamp
John W. Muschamp
Abuse of synthetic psychostimulants like synthetic cathinones has risen in recent years. 3,4‐Methylenedioxypyrovalerone (MDPV) is one such synthetic cathinone that demonstrates a mechanism of action similar to cocaine. Compared to cocaine, MDPV is more potent at blocking dopamine and norepinephrine reuptake and is readily self‐administered by rodents. The present study compared the rewarding and reinforcing properties of MDPV and cocaine using systemic injection dose‐response and self‐administration models. Fifty kilohertz ultrasonic vocalizations (USVs) were recorded as an index of positive affect throughout experiments. In Experiment 1, MDPV and cocaine dose‐dependently elicited 50‐kHz USVs upon systemic injection, but MDPV increased USVs at greater rates and with greater persistence relative to cocaine. In Experiment 2, latency to begin MDPV self‐administration was shorter than latency to begin cocaine self‐administration, and self‐administered MDPV elicited greater and more persistent rates of 50‐kHz USVs versus cocaine. MDPV‐elicited 50‐kHz USVs were sustained over the course of drug load‐up whereas cocaine‐elicited USVs waned following initial infusions. Notably, we observed a robust presence of context‐elicited 50‐kHz USVs from both MDPV and cocaine self‐administering rats. Collectively, these data suggest that MDPV has powerfully rewarding and reinforcing effects relative to cocaine at one‐tenth doses. Consistent with prior work, we additionally interpret these data in supporting that MDPV has significant abuse risk based on its potency and subjectively positive effects. Future studies will be needed to better refine therapeutic strategies targeted at reducing the rewarding effects of cathinone analogs in efforts to ultimately reduce abuse liability.

18 March 2013 in Addiction Biology
Verified
Journal Article
Open access
DBDavid J. Barker
David J. Barker
DBDanielle Bercovicz
Danielle Bercovicz
LSLisa C. Servilio
Lisa C. Servilio
SSSteven J. Simmons
Steven J. Simmons
SMSisi Ma
Sisi Ma
MWMark West
Mark West
Human self‐reports often indicate that changes in mood are a major contributor to drug relapse. Still, arguments have been made that instances of drug‐seeking following abstinence in animal models (i.e. relapse/reinstatement) may be outside of hedonic control. Therefore, the present study utilized ultrasonic vocalizations in the rat in order to evaluate affect during cocaine self‐administration and contextual reinstatement of cocaine‐seeking in a pre‐clinical model of drug relapse (abstinence‐reinstatement model). Results show that while subjects effectively reinstated drug‐seeking (lever pressing) following 30 days of abstinence, and spontaneously recovered/reinstated drug‐seeking following 60 days of abstinence, ultrasonic vocalizations did not increase over baseline levels during either reinstatement session. These results are consistent with previous results from our laboratory and current theories of addiction suggesting that cues that are weakly associated with drug consumption can motivate drug‐seeking behavior that is outside of hedonic processing.

23 November 2024 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
YMYoshikazu Morishita
Yoshikazu Morishita
IFIleana Fuentes
Ileana Fuentes
SGSofia Gonzalez-Salinas
Sofia Gonzalez-Salinas
JFJohn Favate
John Favate
JMJennifer Mejaes
Jennifer Mejaes
GSGleb P. Shumyatsky
Gleb P. Shumyatsky
Fear extinction leads to a decrease of originally acquired fear responses after the threat is no longer present. Fear extinction is adaptive and critical for organism’s survival, but deficits in extinction may lead to exaggerated fear in animals or post-traumatic stress disorder (PTSD) in humans. Dopamine has recently emerged as essential for fear extinction and PTSD, however the neural circuits serving this dopamine function are only beginning to be investigated, and the dopamine intracellular signaling pathways are unknown. We generated gastrin-releasing peptide gene knockout (Grp -/-) mice and found that they exhibit enhanced fear memory in a stress-enhanced fear learning (SEFL) paradigm, which combines stress exposure and fear extinction, two features critical for developing PTSD. Using in vivo fiber photometry to record dopamine signals, we found that the susceptibility of Grp -/- mice to SEFL is paralleled by an increase in basolateral amygdala (BLA) dopaminergic binding during fear conditioning and early extinction. Combined optogenetics and ex vivo electrophysiology showed an increase in presynaptic ventral tegmental area (VTA)-BLA connectivity in Grp -/- mice, demonstrating a role of dysregulated input from the VTA on BLA function in the absence of the GRP. When examining gene transcription using RNA-seq and qPCR, we discovered concerted down-regulation in dopamine-related genes in the BLA of Grp -/- mice following long-term SEFL memory recall that was not observed in naïve conditions. These experiments demonstrate that the GRP regulates dopamine function in stress-enhanced fear processing and identify the Grp as the first gene known to regulate dopaminergic control of fear extinction.

22 November 2022 in Genes, Brain and Behavior
Verified
Journal Article
Open access
SBSvetlana Bryant
Svetlana Bryant
JBJulie‐Anne Balouek
Julie‐Anne Balouek
LGLuke T. Geiger
Luke T. Geiger
DBDavid J. Barker
David J. Barker
CPCatherine J. Peña
Catherine J. Peña
Chronic pain involves both central and peripheral neuronal plasticity that encompasses changes in the brain, spinal cord, and peripheral nociceptors. Within the forebrain, mesocorticolimbic regions associated with emotional regulation have recently been shown to exhibit lasting gene expression changes in models of chronic pain. To better understand how such enduring transcriptional changes might be regulated within brain structures associated with processing of pain or affect, we examined epigenetic modifications involved with active or permissive transcriptional states (histone H3 lysine 4 mono and trimethylation, and histone H3 lysine 27 acetylation) in periaqueductal gray (PAG), lateral hypothalamus (LH), nucleus accumbens (NAc), and ventral tegmental area (VTA) 5 weeks after sciatic nerve injury in mice to model chronic pain. For both male and female mice in chronic pain, we observed an overall trend for a reduction of these epigenetic markers in periaqueductal gray, LH, and NAc, but not VTA. Moreover, we discovered that some epigenetic modifications exhibited changes associated with pain history, while others were associated with individual differences in pain sensitivity. When taken together, these results suggest that nerve injury leads to chronic chromatin‐mediated suppression of transcription in key limbic brain structures and circuits, which may underlie enduring changes in pain processing and sensitivity within these systems.